These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8642798)

  • 1. Imidazoline receptors: from basic concepts to recent developments.
    Bousquet P
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S1-6. PubMed ID: 8642798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imidazoline receptors associated with noradrenergic terminals in the rostral ventrolateral medulla mediate the hypotensive responses of moxonidine but not clonidine.
    Chan CK; Burke SL; Zhu H; Piletz JE; Head GA
    Neuroscience; 2005; 132(4):991-1007. PubMed ID: 15857704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of I1 imidazoline receptors: their role in blood pressure regulation.
    Bousquet P
    Am J Hypertens; 2000 Jun; 13(6 Pt 2):84S-88S. PubMed ID: 10921526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The renaissance of centrally acting antihypertensive drugs.
    van Zwieten PA
    J Hypertens Suppl; 1999 Aug; 17(3):S15-21. PubMed ID: 10489094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does a second generation of centrally acting antihypertensive drugs really exist?
    Feldman J; Greney H; Monassier L; Vonthron C; Bruban V; Dontenwill M; Bousquet P
    J Auton Nerv Syst; 1998 Oct; 72(2-3):94-7. PubMed ID: 9851557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacology of imidazoline receptors and cardiovascular regulation. Imidazoline receptors and blood pressure].
    Bousquet P; Bricca G; Dontenwill M; Feldman J; Belcourt A; Tibiriça E
    Therapie; 1992 Nov; 47(6):525-30. PubMed ID: 1301644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of ligand binding affinities at human I1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes.
    Piletz JE; Zhu H; Chikkala DN
    J Pharmacol Exp Ther; 1996 Nov; 279(2):694-702. PubMed ID: 8930173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Agmatine--an endogenous ligand of imidazoline receptors].
    Kozaeva LP; Korobov NV
    Eksp Klin Farmakol; 2003; 66(5):69-73. PubMed ID: 14650220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological analysis of the role of central alpha-2 adrenergic and imidazoline receptors in mechanism of the hypotensive effect of clonidine in rats].
    Kuz'min AI; Lodygin DN; Kalenikova EI; Bychkova EIu; Khokhlova ON; Murashev AN; Medvedev OS
    Eksp Klin Farmakol; 2000; 63(4):24-8. PubMed ID: 11022301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imidazoline antihypertensive drugs: selective i(1) -imidazoline receptors activation.
    Nikolic K; Agbaba D
    Cardiovasc Ther; 2012 Aug; 30(4):209-16. PubMed ID: 21884004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of NMDA and AMPA/kainate receptors involved in cardiovascular inhibition produced by imidazoline-like drugs in anaesthetized rats.
    Wang LG; Zeng J; Yuan WJ; Su DF; Wang WZ
    Exp Physiol; 2007 Sep; 92(5):849-58. PubMed ID: 17573415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The imidazoline receptors and the central regulation of the arterial blood pressure: a minireview.
    Tibiriça E; Bricca G; Dontenwill M; Feldman J; Greney H; Belcourt A; Stutzmann J; Bousquet P
    Mem Inst Oswaldo Cruz; 1993; 88(2):317-25. PubMed ID: 8107594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is imidazoline site a unique receptor? A correlation with clonidine-displacing substance activity.
    Atlas D; Diamant S; Zonnenschein R
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):83S-90S. PubMed ID: 1317715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of locus coeruleus neurons by non-I1/I2-type imidazoline receptors: an in vivo and in vitro electrophysiological study.
    Ugedo L; Pineda J; Ruiz-Ortega JA; Martín-Ruiz R
    Br J Pharmacol; 1998 Dec; 125(8):1685-94. PubMed ID: 9886760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
    Boronat MA; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of imidazoline receptors in cardiovascular regulation.
    Dontenwill M; Tibiriça E; Greney H; Bennaï F; Feldman J; Stutzmann J; Bricca G; Belcourt A; Bousquet P
    Am J Cardiol; 1994 Dec; 74(13):3A-6A. PubMed ID: 7998582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat clonidine mydriasis model: imidazoline receptors are not involved.
    Yu Y; Koss MC
    Auton Neurosci; 2005 Jan; 117(1):17-24. PubMed ID: 15620566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN; Owens CW; Graham BR
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moxonidine: a new antiadrenergic antihypertensive agent.
    Prichard BN; Graham BR; Owens CW
    J Hypertens Suppl; 1999 Aug; 17(3):S41-54. PubMed ID: 10489098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.